PHC Holdings Corp. (PHCCF)
8.91
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
PHC Holdings Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 23.02M |
| December 31, 2023 | 21.53M |
| September 30, 2023 | 18.55M |
| June 30, 2023 | 19.54M |
| March 31, 2023 | 17.60M |
| December 31, 2022 | 18.64M |
| Date | Value |
|---|---|
| September 30, 2022 | 17.99M |
| June 30, 2022 | 19.08M |
| March 31, 2022 | 22.11M |
| December 31, 2021 | 22.39M |
| September 30, 2021 | 17.54M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CellaVision AB | 3.179M |
| ALR Technologies SG Ltd. | -- |
| M3, Inc. | -- |
| HealthStream, Inc. | 13.58M |
| Simulations Plus, Inc. (DELISTED) | 3.406M |